Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Efficacy Study of Intracerebral CTX0E03 DP in Patients With Stable Paresis of the Arm Following an Ischaemic Stroke.

NCT02117635 is registered in ClinicalTrials.gov with ReNeuron Limited as lead sponsor.

NCT NCT02117635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02117635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Efficacy Study of Intracerebral CTX0E03 DP in Patients With Stable Paresis of the Arm Following an Ischaemic Stroke.
Lead sponsor
ReNeuron Limited
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2014
Completion date
August 16, 2017
Enrollment
23 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

arm paralysis, cerebral infarction, hemiparesis, ischaemic stroke